Articles

Drugs may reduce the risk for diabetes and not cause it as originally believed.

Treatment with inhaled insulin (INH) is associated with an increase in insulin antibodies, but continuing studies indicate that the insulin antibodies are not associated with increased hemoglobin A1c (HA1c), increased need for insulin, hypoglycemia, or allergic reactions.

New studies shows further support for the efficacy of a low-carbohydrate diet.

Enteric-coated aspirin doesn’t inhibit platelets as well as plain aspirin and may not work for preventing cardiovascular disease.

Electronic transmission of blood glucose levels data —in lieu of a clinic visit—results in a similar level of glucose control and incidence of acute diabetes complications when compared with current standard care.

Half the patients lost 5 percent of their body weight and one-quarter lost 10 percent of their body weight.

New research reveals that a prospective treatment for autoimmune diseases such as diabetes and multiple sclerosis can result in serious side effects in mice. The researchers from Stanford University found that 86% of the diabetic mice they treated with peptide immunotherapy died as a result.

New Zealand doctors have made a discovery that could have implications for twins across the world.

A continuous subcutaneous glucose monitoring system improves metabolic control in pediatric patients with type 1 diabetes.

Women with pregestational type 1 diabetes who experience stillbirths are more likely to have suboptimal glycemic control during pregnancy.